Elections have consequences, former President Barack Obama once quipped. As usual, his words have aged well, though perhaps not to his liking. Ahead of confirmation hearings, one nomination — that of Robert F. Kennedy leading the Department of Health and Human Services — has several entities, including soft-drink giant Coca-Cola (KO), worried.
Long an American icon, Coca-Cola and its ilk received a harsh reality check following the results of the 2024 election. Kennedy has pledged sweeping reforms at the U.S. Food and Drug Administration (FDA), which naturally impact pharmaceutical companies. However, his broader promise to “Make America Healthy Again” should raise alarms for investors of KO stock.
